Author

Philip A. Philip

Henry Ford HealthORCID 0000-0002-6513-3491Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Adeeb Aboukameel· 1 shared Adnan R. Munkarah· 1 shared Amro AboukameeliD· 1 shared Asfar S. Azmi· 1 shared Bassel F. El‐RayesiD· 1 shared Bin Bao· 1 shared Boris PascheiD· 1 shared Faraz RashidiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adeeb Aboukameel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 10, 2025

PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer

Sahar F. Bannoura, Husain Yar Khan, Amro Aboukameel…·Asfar S. Azmi

This study shows that combining PCNA inhibitor AOH1996 with KRAS inhibitors enhances antitumor activity in pancreatic cancer models.

2 citations

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Ovarian ResearchPeer-reviewedNov 14, 2024

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Mary Priyanka Udumula, Faraz Rashid, Harshit Singh…·Ramandeep Rattan

This study shows CPI-613 reduces tumor growth in chemoresistant ovarian tumors by inhibiting mitochondrial function and enhancing chemotherapy response.

22 citations

mousebulk RNA-seq

𝕏 PostBluesky